Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Hepatocellular carcinoma risk diminishes with time following HCV eradication

Hepatocellular carcinoma risk diminishes with time following HCV eradication

30 Nov 2023

Among individuals with cirrhosis and cured hepatitis C virus (HCV) infection, the risk of hepatocellular carcinoma tapers off progressively through 6 years after HCV eradication, as shown in a study. However, the risk remains above thresholds that require screening.

Hepatocellular carcinoma risk diminishes with time following HCV eradication

30 Nov 2023
Mediterranean diet helps with gastrointestinal, psychological symptoms in IBS

Mediterranean diet helps with gastrointestinal, psychological symptoms in IBS

30 Nov 2023
Transcutaneous neuromodulation improves symptoms in functional dyspepsia

Transcutaneous neuromodulation improves symptoms in functional dyspepsia

29 Nov 2023

Patients with functional dyspepsia (FD) may benefit from transcutaneous neuromodulation (TN) treatment, which can significantly improve symptoms and quality of life, according to a study.

Transcutaneous neuromodulation improves symptoms in functional dyspepsia

29 Nov 2023
Novel tri-agonist confers significant gains for MASLD patients

Novel tri-agonist confers significant gains for MASLD patients

24 Nov 2023 bởiAudrey Abella

In a substudy of a phase II obesity trial, individuals with MASLD* and obesity benefited significantly from retatrutide, a once-weekly, injectable, novel synthetic molecule that has shown potent agonist action at GIP**, GLP-1***, and glucagon receptors.

Novel tri-agonist confers significant gains for MASLD patients

24 Nov 2023